Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:DNLI News 10 December 2025 - 29 January 2026

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics shares rose 3.7% to $21.62 Thursday after the FDA halted Regenxbio’s gene therapy trials over a brain tumor case, intensifying focus on Denali’s Hunter syndrome drug under FDA review. Investors await Denali’s clinical data update in early February and a regulatory decision by April 5. The iShares Nasdaq Biotechnology ETF was little changed.
29 January 2026
·····
US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

Despite a Fed-fueled rally that pushed major US indices toward record highs, a cluster of high‑profile stocks sank sharply on Wednesday. Here’s what drove today’s biggest losers — and what Wall Street is saying next. Market recap: Fed cut fuels rally, but pockets of pain emerge New York — December 10, 2025. Wall Street finished the day higher after the Federal Reserve delivered a widely expected 25‑basis‑point rate cut, its third cut of 2025, taking the federal funds target range down to roughly 3.50%–3.75%.Reuters+2Investopedia+2 The S&P 500 and Dow Jones Industrial Average both advanced and flirted with all‑time highs, while
10 December 2025
···········

Stock Market Today

Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop